National Diabetes Month: Calling All DFU Avengers

November is National Diabetes Month. Did you know that every 1.2 seconds, someone develops a diabetic foot ulcer (DFU)1, of which 50% of DFUs will become infected, and of those, 20% result in amputation?2,3

At Amniox Medical, we empower healthcare professionals to deliver optimal patient healing outcomes with our family of products made from cryopreserved umbilical cord and amniotic membrane.

Click here to download the infographic to share with your patients


Dr. Thomas Fusco, DPM

Foot & Ankle Specialist and Podiatric Surgeon with Orthopaedic Associates
Fort Walton Beach, FL.

Jim Bishop, Amniox Sales Rep

Jim was working with a doctor who was frustrated with a non-healing complex chronic wound on one of his terminally ill patients. The patient had wounds in both feet that had not healed over one and a half years. Jim asked the doctor for the chance to show him what NEOX could do for that patient. The patient, a 47-year-old male, had lost all ten of his toes to amputation and had other comorbidities, including type 2 diabetes and pancreatic cancer. The doctor was sure he’d need to amputate this patient’s legs if his wounds did not heal. He had already tried other allografts that failed to achieve closure. The doctor placed two NEOX Cord 1K applications on the right foot, which completely healed after two months, and the left foot required three applications. When Jim saw the patient during his final application of NEOX, the patient held a new pair of custom-made orthopedic shoes and was ecstatic to wear shoes again. He thanked Jim profusely and said, “Even if I ‘go’ soon, I am so happy to be able to walk and enjoy my family now!”

Advance Wound Therapy. Beyond Compare.

With the NEOX® line of cryopreserved umbilical cord allografts and injectables

Supports regenerative healing and functional recovery for a variety of wounds—ranging from common surgical wounds to complex chronic wounds4-11

  • Higher closure rates5-11
  • Fewer applications5-11
  • Reduced cost of care

The Difference is Our Scientific Platform

For over 30 years, our pioneering scientists have focused on understanding the regenerative features of human birth tissue—ultimately identifying HC-HA/PTX3 as the key orchestrator in human birth tissue regenerative healing.4

Our CRYOTEK® Cryopreservation Process has been shown to preserve the structural and functional integrity of the HC-HA/PTX3 complex significantly better than heat dehydration—delivering the benefits of the natural tissue to the wound.4,11

Key Webinars

One-year safety, Healing and Amputation Rates of Wagner 3-4 Diabetic Foot Ulcers Treated with Cryopreserved Umbilical Cord by William A. Marston, MD

In this webinar, Dr. William A. Marston will be showcasing the results from the one-year follow-up study to the Phase 2 open label, multicenter pilot study of Cryopreserved Umbilical Cord (cHUC) allograft TTAX01 for the treatment of Wagner Grade 3-4 diabetic foot ulcers (DFUs).

Surgical Augmentation and Wound Management in Lower Extremities by Mark Gould, MD and Eric Giza, MD

This webinar will be a contemporary overview of these regenerative tissues, where expert physicians will review the underlying biology, present their clinical experience, and share challenging cases specific to a variety of lower extremity applications.

Cryopreserved Umbilical Cord Allograft to Treat Wagner Grade 3-4 DFUs

In support of Wound Healing Awareness Month (WHAM), we held a successful live webinar, led by Dr. William Marston on the use of Cryopreserved Umbilical Cord Allograft to Treat Wagner Grade 3-4 DFUs. Dr. Marston’s findings revealed positive outcomes from the 1-year follow-up of this pilot study and a promising future in the treatment of complex chronic wounds. This is the first study to tackle the treatment of Wagner Grade 3-4 DFUs.

You can watch the webinar recording at your convenience by signing up in our Physician Portal at by clicking here. Once registered, you can find the webinar under Virtual Events in the Webinar Archive.

  • Request More Information
    Learn more about how our family of products can orchestrate regenerative healing for better patient outcomes. Fill out the form below and a representative will contact you shortly.
  • By clicking the button below, I agree to receive marketing communications from Amniox I am aware that I can unsubscribe at any time.Privacy PolicyDo Not Sell My Personal Information


1. Armstrong, Boulton, Bus, NEJM, 2017
2. Armstrong, et al., N Eng J Med 2017; Prompers et al., Diabetologia 2007
3. Lipsky et al., Clin Infect Dis 2012
4. Tseng SC. Invest Ophthalmol Vis Sci. 2016;57(5):ORSFh1‐ORSFh8.
5. Caputo WJ, Vaquero C, Monterosa A, et al. Wound Repair Regen. 2016;24(5):885-893.
6. Couture M. Wounds. 2016;28(7):217-25.
7. Marston WA, Lantis JC 2nd, Wu SC, et al. Wound Repair Regen. 2019;27(6):680-86.
8. Marston WA, Lantis JC 2nd, Wu SC, et al. Wound Repair Regen. 2020. Online ahead of print.
9. Raphael A. J Wound Care. 2016;25(Sup7):S10-17.
10. Raphael A, Gonzales J. J Wound Care. 2017;26(Sup10):S38-44.
11. Cooke M, Tan EK, Mandrycky C, He H, O’Connell J, Tseng SC. J Wound Care. 2014;23(10):465‐476.